Anna Windle, PhD, is Senior Vice President, NAO Clinical Development, Medical & Regulatory Affairs at Novo Nordisk Inc., a role she assumed in August 2022. She leads an integrated team across drug development, clinical operations, medical, regulatory, health economics and outcomes research, and safety. Anna is also responsible for the efficient development and delivery of compounds in clinical trials, including product lifecycle and in-licensed compounds.

Since joining the company in 2011, Anna has played a key role in advancing Novo Nordisk's diabetes, obesity and rare disease clinical development pipelines, leading both in-house and field Medical Affairs teams in strategy development, operations, and key customer engagement planning and execution.

Anna has worked in the healthcare sector for more than 20 years, including in several leadership roles building and leading Medical Affairs functions. Prior to joining Novo Nordisk, Anna led the Medical Affairs function at QLT Therapeutics Inc., based in Vancouver, Canada, where she established the team and oversaw development of the internal infrastructure.

Prior to that, Anna held various roles of increasing responsibility at Novartis, including Therapeutic Team Director responsible for Respiratory and CV Medical Liaison teams in the West region. In addition to developing plans for medical support of commercialized brands and bringing several collaborative research projects to fruition, Anna led the Ophthalmology National field team.

Anna began her professional career working at GSK as a Regional Medical Scientist after earning a Doctor of Philosophy in Physiology from the University of Melbourne and completing a Post-Doctoral Fellowship in Neuroscience at the University of California, San Francisco. Anna holds a Bachelor of Science degree from the University of Melbourne and has completed three professional programs, including the BioExecutive Institute and Women in Leadership at the Walter Haas School of Business at Berkeley, as well as a Certificate in Business Leadership from Wharton Business School at the University of Pennsylvania.

In addition to her professional and academic accomplishments, she has published five research papers, including in the Journal of Physiology, the International Society for Autonomic Neuroscience, Journal of Applied and Natural Science, and Proceedings of the Australian Neuroscience Society.